AI in Monitoring and Recruitment Fueled by the rising prevalence of chronic diseases, increased adoption of telehealth services and advancements in AI technologies, the AI in remote patient monitoring (RPM) market is poised for rapid expansion projected to grow from $1.96 billion in 2024 to $8.43 billion by 2030, at a 27.5% CAGR
Association of extracellular vesicle biomarkers with alzheimer disease in the Baltimore longitudinal study of aging
High-performance liquid chromatography (HPLC) investigations have identified several bioactive compounds, primarily withaferin A and withanolide A, which are likely responsible for the protective effects of W
Compounded therapies may be prescribed only when a licensed prescriber determines they are clinically appropriate for an identified patient, including when a prescriber documents a clinically significant difference for that patient
Some research teams use 6-week on, 4-week off cycling to maintain metabolic responsiveness across multiple cycles
Metabolisme 32 (5), 930935
